Reports Q4 revenue $20.3B, consensus $20.45B. Identical sales increased 0.7%; Digital sales increased 16%. “Fiscal 2025 was a year of disciplined execution and resilience, as we closed the year with a solid fourth quarter that delivered strong Adjusted EBITDA despite meaningful top-line pharmacy-related headwinds,” said Susan Morris, CEO. “Across the full year, we remained focused on building a stronger foundation for the future, including investing in our customer value proposition, advancing digital and loyalty, and strengthening the capabilities that support sustainable, long-term growth. As we enter fiscal 2026, we are building on this foundation by scaling our productivity engine and positioning the company to deliver earnings growth, strong cash flow, and long-term shareholder returns.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACI:
- Options Volatility and Implied Earnings Moves Today, April 14, 2026
- These Are the Stocks Reporting Earnings Today – April 14, 2026
- Notable companies reporting before tomorrow’s open
- Options Volatility and Implied Earnings Moves This Week, April 13 – April 17, 2026
- ACI Earnings this Week: How Will it Perform?
